Vascular Embolization

Vascular Embolization Market Outlook

The global vascular embolization market is projected to reach approximately USD 5.2 billion by 2035, growing at a compound annual growth rate (CAGR) of around 7.4% from 2025 to 2035. This growth is driven by an increasing prevalence of vascular diseases and the rising adoption of minimally invasive procedures in various medical specialties. Furthermore, advancements in embolization technologies and the development of novel embolic agents are expected to enhance treatment outcomes, thereby propelling market expansion. Additionally, the growing geriatric population is more susceptible to vascular disorders, which significantly contributes to the demand for vascular embolization procedures. The rise in healthcare expenditure and the expansion of healthcare infrastructure in emerging markets will also act as a catalyst for market growth.

Growth Factor of the Market

The vascular embolization market is significantly influenced by various growth factors, which are driving its expansion on a global scale. One of the primary factors is the increasing incidence of cancers, which often require embolization procedures for effective treatment. Furthermore, the rise in chronic diseases such as cardiovascular diseases and peripheral vascular diseases has led to a growing need for innovative vascular interventions. Technological advancements in embolization techniques, including the development of more effective embolic agents and delivery systems, have improved the safety and efficacy of these procedures, thus encouraging more healthcare providers to adopt them. Additionally, the trend toward outpatient surgical procedures is creating a favorable environment for the growth of the ambulatory surgical centers segment. Moreover, the rising awareness of minimally invasive surgeries among patients is fostering an increase in demand for vascular embolization procedures.

Key Highlights of the Market

• The vascular embolization market is projected to grow at a CAGR of 7.4% from 2025 to 2035.
• Coil embolization is anticipated to dominate the product type segment due to its extensive applications.
• Oncology applications are expected to hold the largest market share owing to the rising cancer prevalence.
• North America is the leading region in the vascular embolization market due to advanced healthcare infrastructure.
• Technological innovations and development of biodegradable embolic materials are expected to offer new growth opportunities.

By Product Type

Coil Embolization:

Coil embolization is a prominent technique utilized in vascular embolization procedures. This method involves the insertion of metallic coils into blood vessels, leading to occlusion. The coils are made from various materials, including platinum, which ensures biocompatibility and effective thrombosis. The increasing prevalence of conditions such as aneurysms and arteriovenous malformations has significantly contributed to the demand for coil embolization. This method is preferred in many clinical settings due to its versatility and effectiveness in various anatomical locations. Additionally, advancements in coil design, such as the introduction of bioactive coils, have improved clinical outcomes and patient safety, further solidifying its position in the market.

Particle Embolization:

Particle embolization involves the use of small particles to occlude blood vessels selectively. This method is particularly effective in treating tumors and vascular malformations, as it allows for targeted delivery of the embolic agent. The particles can vary in size and composition, including polyvinyl alcohol (PVA) particles and microspheres, which enhance their effectiveness. The rising incidence of tumors, especially in the oncology application segment, is a key driver for the growth of this product type. Furthermore, the ability to perform particle embolization through minimally invasive techniques has made it a preferred choice among healthcare providers, contributing to its increasing market share.

Liquid Embolics:

Liquid embolics are a unique type of embolic agent that can completely fill the target vessel, leading to effective occlusion. These agents, such as glue and sclerotherapy agents, are particularly useful in treating complex vascular lesions. Liquid embolics provide several advantages, including the ability to navigate through tortuous vessels and control the flow of the embolic agent. The growing adoption of liquid embolics can be attributed to their effectiveness in providing complete occlusion, which is often required in challenging cases. As the demand for advanced embolization techniques continues to rise, the liquid embolics segment is expected to gain traction in the vascular embolization market.

Embolization Guidewires:

Embolization guidewires play a crucial role in the vascular embolization process by facilitating the precise delivery of embolic agents. These guidewires are designed with advanced technology to ensure enhanced maneuverability and support during the procedure. The increasing number of interventional procedures and the growing preference for minimally invasive techniques are pivotal factors driving the demand for embolization guidewires. Innovations in guidewire designs, such as enhanced flexibility and visibility, are enhancing their effectiveness and safety in guiding embolic materials to the target site. As the market for vascular interventions continues to expand, the embolization guidewires segment is poised for significant growth.

Embolization Catheters:

Embolization catheters are essential tools used to deliver embolic agents directly to the target vessel. They come in various shapes and sizes, catering to diverse anatomical requirements. The increasing number of interventional procedures, particularly in oncology and vascular surgery, is driving the demand for specialized embolization catheters. These devices are engineered for optimal performance, with features such as hydrophilic coatings and advanced tip designs that facilitate navigation through complex vascular structures. The growing trend towards minimally invasive techniques has further propelled the use of embolization catheters, as they provide enhanced precision and reduce recovery times for patients.

By Application

Oncology:

The oncology application segment is a significant driver of the vascular embolization market. Embolization is increasingly utilized as a treatment modality for various tumors, including liver, kidney, and uterine tumors. The ability to selectively occlude blood supply to the tumor enhances the effectiveness of other treatment methods, such as chemotherapy and radiation therapy, thereby improving patient outcomes. The growing incidence of cancer globally is further propelling the demand for embolization techniques. As healthcare providers seek innovative approaches to cancer treatment, the oncology segment is expected to witness continued growth, reflecting the need for advanced therapeutic options.

Neurology:

In the neurology application segment, vascular embolization plays a critical role in managing conditions such as arteriovenous malformations and intracranial aneurysms. The minimally invasive nature of embolization procedures makes them a preferred choice for neurological interventions, as they offer reduced patient trauma and faster recovery times. The rising incidence of neurological disorders, combined with advancements in embolic techniques, is driving the growth of this segment. Furthermore, technological improvements in imaging and navigation during these procedures have enhanced the precision of embolization, making it a vital component in the management of neurological conditions.

Cardiology:

The cardiology application segment utilizes vascular embolization techniques to treat various cardiovascular diseases. Procedures such as cardiac catheterization may integrate embolization techniques for managing conditions like ischemic heart disease and coronary artery malformations. The growing prevalence of cardiovascular diseases, driven by lifestyle changes and an aging population, is significantly contributing to the demand for embolization in cardiology. Moreover, advancements in catheter technology and embolic agents have improved the safety and efficacy of these procedures, further solidifying the cardiology segment's importance in the vascular embolization market.

Urology:

In urology, vascular embolization is increasingly employed to manage conditions like renal tumors and vascular malformations. This application allows for targeted treatment while minimizing damage to surrounding healthy tissues. The rise in renal disorders, coupled with the growing emphasis on organ preservation in cancer treatment, is driving the demand for embolization techniques in urology. As urological interventions continue to evolve, the use of embolization for both therapeutic and palliative purposes is expected to expand, contributing to the segment's growth in the vascular embolization market.

Peripheral Vascular Diseases:

Peripheral vascular diseases (PVD) represent a significant segment within the vascular embolization market, encompassing conditions such as peripheral artery disease and deep vein thrombosis. The application of embolization techniques in PVD is vital for managing occlusions and restoring blood flow. The increasing prevalence of risk factors associated with PVD, such as diabetes and obesity, is driving the demand for vascular interventions. Additionally, advancements in embolic materials and techniques have improved treatment outcomes for patients with PVD, further enhancing the segment's growth prospects in the vascular embolization market.

By Distribution Channel

Hospitals:

Hospitals serve as the primary distribution channel for vascular embolization products, catering to a broad patient demographic. The presence of specialized departments, such as interventional radiology and oncology, enables hospitals to offer comprehensive embolization services. The growing volume of surgical procedures performed in hospitals, combined with the increase in patient admissions for vascular conditions, is driving the demand for embolization products in this segment. Furthermore, hospitals often have access to advanced imaging and surgical technologies, which enhance the efficacy of embolization procedures, thereby boosting market growth.

Specialty Clinics:

Specialty clinics focusing on vascular interventions are a crucial distribution channel for embolization products. These clinics often offer specific services tailored to particular patient needs, which allows for personalized treatment approaches. The rise in outpatient surgical procedures is driving the growth of specialty clinics, as they provide patients with high-quality care in a convenient setting. Additionally, the increasing awareness of minimally invasive techniques is propelling more patients to seek treatment at specialty clinics, contributing to the growing demand for vascular embolization products in this channel.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming increasingly vital in the distribution of vascular embolization products, particularly due to the trend towards outpatient procedures. These centers offer a more cost-effective solution for patients seeking minimally invasive interventions without the need for lengthy hospital stays. The growing preference for outpatient care, along with advancements in surgical technologies, is driving the demand for embolization procedures in ASCs. As more patients opt for these centers for their vascular interventions, the market for embolization products in this distribution channel is expected to flourish.

Catheterization Laboratories:

Catheterization laboratories, commonly found in hospitals and specialized clinics, are essential for performing interventional procedures, including vascular embolization. These labs are equipped with advanced imaging technologies that enhance the accuracy and safety of embolization procedures. The increasing prevalence of cardiovascular and vascular diseases is driving the demand for catheterization laboratories, as more healthcare providers are utilizing these facilities for complex interventional procedures. The continuous advancements in catheter and embolic agent technologies are further enhancing the capabilities of catheterization laboratories, contributing to their pivotal role in the vascular embolization market.

By Ingredient Type

Polyvinyl Alcohol Particles:

Polyvinyl alcohol (PVA) particles are widely used in vascular embolization due to their efficacy in occluding blood vessels. These particles are biocompatible and can be used effectively in various applications, including oncology and urology. PVA particles are known for their ability to create a permanent occlusion, making them ideal for treating hypervascular tumors and arterial malformations. The increasing adoption of PVA particles in embolization procedures is driven by their proven effectiveness and the growing demand for minimally invasive treatment options. As more healthcare providers recognize the benefits of PVA particles, their market share in the vascular embolization segment is expected to increase significantly.

Microspheres:

Microspheres are another essential ingredient type used in vascular embolization procedures. They offer several advantages, including precise sizing and the ability to deliver targeted therapy. These microspheres can be utilized in various applications, particularly in oncology, where they effectively occlude blood flow to tumors. The biocompatibility of microspheres and their ability to be loaded with therapeutic agents enhances their effectiveness in embolization procedures. As the demand for targeted therapies continues to rise, the use of microspheres in embolization is expected to grow, reflecting the evolving landscape of vascular interventions.

Coils:

Coils are a fundamental component of vascular embolization, providing a reliable method for occluding blood vessels. These devices are typically composed of various materials, including platinum, which ensures both safety and efficacy. Coils can be used in various applications, particularly for treating aneurysms and vascular malformations. The increasing complexity of vascular interventions and the rising prevalence of conditions requiring embolization are driving the demand for coils. Innovations in coil design, including advancements in delivery techniques, are further enhancing their utility in clinical settings, contributing to the growth of this ingredient type in the vascular embolization market.

Liquid Embolics:

Liquid embolics represent a distinct ingredient type utilized in vascular embolization procedures. These agents can be injected directly into blood vessels, allowing for complete occlusion. Liquid embolics are particularly beneficial in treating complex vascular lesions and tumors, as they can conform to various vessel shapes. The increasing adoption of liquid embolics can be attributed to their effectiveness in achieving desired clinical outcomes and their ability to minimize patient trauma. As healthcare providers increasingly seek innovative approaches to vascular interventions, the use of liquid embolics is expected to gain traction in the vascular embolization market.

Gelatin:

Gelatin is a biodegradable material used in vascular embolization, often in the form of gelatin sponge particles. Its biocompatibility and absorbability make it a favorable choice for temporary embolization, especially in procedures where complete occlusion is not necessary. The use of gelatin in vascular interventions is gaining popularity due to its efficacy and the rising demand for biodegradable materials in medical applications. As the emphasis on patient safety and biocompatibility continues to grow, the gelatin segment in the vascular embolization market is likely to expand, reflecting the industry's shift towards more sustainable practices.

By Region

The regional analysis of the vascular embolization market indicates that North America holds the largest share, driven by advanced healthcare infrastructure and a high prevalence of vascular diseases. The region is expected to exhibit a CAGR of around 7.5% from 2025 to 2035, attributed to the increasing adoption of innovative embolization technologies and a growing number of interventional procedures. The United States, in particular, has a well-established healthcare system, leading to significant investments in advanced medical technologies, which boost the demand for vascular embolization products. The heightened awareness of minimally invasive procedures among patients and healthcare providers further contributes to market growth in North America.

Europe is also a significant market for vascular embolization, accounting for a substantial share due to the increasing incidence of chronic diseases and advancements in embolization techniques. The growing geriatric population in Europe poses a significant risk factor for vascular disorders, thereby elevating the demand for effective treatment options. The presence of key market players and ongoing research and development activities in the region are expected to propel the vascular embolization market forward. Furthermore, the implementation of favorable government policies to enhance healthcare access and affordability will also strengthen the market's growth prospects in Europe.

Opportunities

The vascular embolization market presents numerous opportunities for stakeholders, particularly with the rapid advancements in technology. Innovative developments in embolic materials, such as biodegradable agents and targeted delivery systems, are opening new avenues for effective treatments. As researchers continue to explore the potential of these materials, manufacturers can capitalize on the growing trend towards personalized medicine, which emphasizes tailored treatment plans based on individual patient needs. Additionally, the rise in outpatient procedures offers a lucrative opportunity for healthcare providers to expand their services, leading to increased patient access to embolization therapies. Collaborations between industry players and research institutions can also foster innovation and drive the development of cutting-edge embolization technologies, further enhancing market prospects.

Moreover, the increasing global awareness regarding vascular health and the importance of early diagnosis is creating a favorable environment for the vascular embolization market. Educational initiatives aimed at healthcare professionals and the general public can enhance knowledge about the benefits of embolization procedures, subsequently driving demand. As healthcare systems worldwide prioritize preventive care and minimally invasive interventions, there is a growing opportunity for manufacturers to develop training programs and workshops to equip healthcare providers with the necessary skills and knowledge for effective embolization procedures. The emergence of telemedicine and remote consultation services also presents opportunities for expanding patient outreach and improving access to vascular embolization interventions.

Threats

Despite the promising growth of the vascular embolization market, several threats could hinder its trajectory. One of the primary concerns is the stringent regulatory environment governing medical devices and procedures. Regulatory approval processes can be lengthy and complex, which may delay the introduction of innovative embolization products and technologies. Additionally, the high costs associated with embolization procedures can pose a barrier to patient access, particularly in developing regions where healthcare budgets are limited. The presence of alternative treatment options, such as surgical interventions and pharmacological therapies, may also divert patient preference away from embolization techniques, affecting market growth.

Moreover, the increasing competition among key players in the vascular embolization market can lead to price wars, adversely impacting profit margins. As manufacturers seek to differentiate their products, they may engage in aggressive pricing strategies that could compromise quality and safety standards. The rising trend of consolidation within the healthcare industry may also limit opportunities for smaller players to compete effectively. Additionally, the ongoing economic fluctuations and uncertainty arising from global events, such as pandemics or geopolitical tensions, may disrupt supply chains and affect the overall market dynamics for vascular embolization products.

Competitor Outlook

• Medtronic plc
• Boston Scientific Corporation
• Terumo Corporation
• Abbott Laboratories
• Johnson & Johnson
• Stryker Corporation
• Cook Medical
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Merit Medical Systems, Inc.
• Cardinal Health, Inc.
• Penumbra, Inc.
• Ethicon, Inc.
• Fenestration Medical
• Inari Medical, Inc.

The competitive landscape of the vascular embolization market is characterized by the presence of several prominent players dedicated to enhancing patient outcomes through innovative embolization solutions. Leading companies such as Medtronic plc and Boston Scientific Corporation have established themselves as key players, leveraging their extensive research and development capabilities to introduce advanced embolic materials and technologies. These organizations continually invest in product innovation to meet the evolving needs of healthcare providers and patients. Additionally, strategic collaborations and partnerships among industry players are becoming increasingly prevalent, as companies aim to enhance their product offerings and expand their market presence. The growing trend of mergers and acquisitions also reflects the competitive nature of the market, as companies seek to strengthen their portfolios and gain access to new technologies.

Medtronic plc stands out in the vascular embolization market with its comprehensive portfolio of products, including embolization coils, particles, and liquid embolics. The company's commitment to research and development has enabled it to remain at the forefront of innovation, consistently introducing cutting-edge technologies that enhance the safety and efficacy of embolization procedures. Medtronic's strong global presence and established distribution networks further bolster its competitive advantage. Boston Scientific Corporation also plays a significant role in the market, offering a wide range of interventional products. Their focus on minimally invasive techniques and continuous innovation positions them as a formidable competitor in the vascular embolization space.

Other key players, such as Abbott Laboratories and Cook Medical, continue to make significant contributions to the market through their advanced embolization offerings. Abbott has made substantial investments in developing novel embolic agents that cater to diverse medical applications, while Cook Medical emphasizes the importance of procedural efficiency and patient safety in their product designs. Furthermore, the rising prominence of startups and smaller companies specializing in niche embolization technologies is reshaping the competitive landscape. These organizations often focus on targeted therapies and innovative materials, presenting unique opportunities for collaboration and growth within the vascular embolization market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cook Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Ethicon, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic plc
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Penumbra, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Terumo Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 AngioDynamics, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Inari Medical, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stryker Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Fenestration Medical
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cardinal Health, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Asahi Intecc Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Merit Medical Systems, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Vascular Embolization Market, By Application
    • 6.1.1 Oncology
    • 6.1.2 Neurology
    • 6.1.3 Cardiology
    • 6.1.4 Urology
    • 6.1.5 Peripheral Vascular Diseases
  • 6.2 Vascular Embolization Market, By Product Type
    • 6.2.1 Coil Embolization
    • 6.2.2 Particle Embolization
    • 6.2.3 Liquid Embolics
    • 6.2.4 Embolization Guidewires
    • 6.2.5 Embolization Catheters
  • 6.3 Vascular Embolization Market, By Ingredient Type
    • 6.3.1 Polyvinyl Alcohol Particles
    • 6.3.2 Microspheres
    • 6.3.3 Coils
    • 6.3.4 Liquid Embolics
    • 6.3.5 Gelatin
  • 6.4 Vascular Embolization Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Catheterization Laboratories

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Vascular Embolization Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Vascular Embolization market is categorized based on

By Product Type

• Coil Embolization
• Particle Embolization
• Liquid Embolics
• Embolization Guidewires
• Embolization Catheters

By Application

• Oncology
• Neurology
• Cardiology
• Urology
• Peripheral Vascular Diseases

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Catheterization Laboratories

By Ingredient Type

• Polyvinyl Alcohol Particles
• Microspheres
• Coils
• Liquid Embolics
• Gelatin

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Boston Scientific Corporation
• Terumo Corporation
• Abbott Laboratories
• Johnson & Johnson
• Stryker Corporation
• Cook Medical
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Merit Medical Systems, Inc.
• Cardinal Health, Inc.
• Penumbra, Inc.
• Ethicon, Inc.
• Fenestration Medical
• Inari Medical, Inc.